Neuropathy News and Research RSS Feed - Neuropathy News and Research

Blocking molecular signaling pathway could prevent or reverse peripheral neuropathy

Blocking molecular signaling pathway could prevent or reverse peripheral neuropathy

Researchers at University of California San Diego School of Medicine, with colleagues at the National Institute of Diabetes and Digestive and Kidney Diseases, the University of Manitoba and St. Boniface Hospital Albrechtsen Research Centre in Canada, have identified a molecular signaling pathway that, when blocked, promotes sensory neuron growth and prevents or reverses peripheral neuropathy in cell and rodent models of type 1 and 2 diabetes, chemotherapy-induced neuropathy and HIV. [More]
Research reveals causes of motor abnormalities in low birth weight babies

Research reveals causes of motor abnormalities in low birth weight babies

In the February issue of the American Journal of Pathology, new research from the University of Chicago shows motor abnormalities frequently associated with low birth weight babies could originate due to peripheral nerve defects. [More]
ACP's clinical practice guidelines recommend effective treatment strategy for type 2 diabetes

ACP's clinical practice guidelines recommend effective treatment strategy for type 2 diabetes

Physicians should prescribe metformin to patients with type 2 diabetes when medication is needed to improve high blood sugar, the American College of Physicians (ACP) recommends in an evidence-based clinical practice guideline published today in Annals of Internal Medicine. [More]
Hospitals eliminate bedsore occurrence using early detection technology

Hospitals eliminate bedsore occurrence using early detection technology

Using technology adapted from NASA's Mars lander as part of a large-scale bedsore reduction program, over half of the 13 participating hospitals were able to eliminate the occurrence of new bedsores completely; an additional 3 hospitals achieved reductions ranging from 11% to 90%. [More]
Person's ‘brain speed’ may matter more than other risk factors for geriatric falls

Person's ‘brain speed’ may matter more than other risk factors for geriatric falls

"Why does a 30-year-old hit their foot against the curb in the parking lot and take a half step and recover, whereas a 71-year-old falls and an 82-year-old falls awkwardly and fractures their hip?" asks James Richardson, M.D., professor of physical medicine and rehabilitation at the University of Michigan Comprehensive Musculoskeletal Center. [More]
New book provides insights into latest treatments for partial blindness

New book provides insights into latest treatments for partial blindness

In Restoring Low Vision, renowned neuroscientist Bernhard Sabel explains cutting-edge science in language that patients can easily understand and provides a comprehensive look at the latest treatments for partial blindness. [More]
Type 2 diabetes linked to long list of complications that can affect health and quality of life

Type 2 diabetes linked to long list of complications that can affect health and quality of life

T2D Lifestyle, a national survey by Health Union of more than 400 individuals living with type 2 diabetes (T2D), reveals that patients not only struggle with commonly understood complications, but also numerous lesser known ones that people do not associate with diabetes. [More]
Karolinska Institute biologist receives 2016 Naomi Berrie Award for excellence in diabetes research

Karolinska Institute biologist receives 2016 Naomi Berrie Award for excellence in diabetes research

Columbia University has awarded the 2016 Naomi Berrie Award for Outstanding Achievement in Diabetes Research to Peter Arner, MD, PhD, a Distinguished Professor in the Department of Medicine at the Karolinska Institute, whose studies on the turnover of fat tissue in the human body has revealed processes that contribute to obesity and diabetes. [More]
Melanoma drug offers considerable added benefit for patients with advanced NSCLC

Melanoma drug offers considerable added benefit for patients with advanced NSCLC

Pembrolizumab was initially introduced for the treatment of melanoma. Since July 2016, the monoclonal antibody has also been available for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) in adults whose tumours express the T-cell receptor ligand PD-L1 and who have received a prior chemotherapy regimen. [More]
GW scientist awarded $2.8 million NIH grant to continue research on corneal wound healing

GW scientist awarded $2.8 million NIH grant to continue research on corneal wound healing

George Washington University researcher Mary Ann Stepp, Ph.D., received a $2.8 million, five-year R01 grant from the National Institutes of Health to continue her 27 years of research on corneal wound healing. [More]
Scientists identify commonly affected genes sets among people with three mental disorders

Scientists identify commonly affected genes sets among people with three mental disorders

Studying brain tissue from deceased donors, Johns Hopkins scientists have found common groups of genes disrupted among people with schizophrenia, bipolar disorder and major depression. [More]
FDA approves new therapy for initial treatment of soft tissue sarcoma

FDA approves new therapy for initial treatment of soft tissue sarcoma

The U.S. Food and Drug Administration today granted accelerated approval to Lartruvo (olaratumab) with doxorubicin to treat adults with certain types of soft tissue sarcoma (STS), which are cancers that develop in muscles, fat, tendons or other soft tissues. [More]
New review looks at complexity of fracture epidemiology in diabetes

New review looks at complexity of fracture epidemiology in diabetes

Due to the ageing of populations as well as increasing obesity and adverse lifestyle factors, type 2 diabetes (T2D) is reaching epidemic proportions in many parts of the world. [More]
High folate intake may increase risk of peripheral neuropathy in older adults with common gene variant

High folate intake may increase risk of peripheral neuropathy in older adults with common gene variant

Consuming too much folate (vitamin B9) is associated with increased risk for a nerve-damage disorder in older adults who have a common genetic variant. [More]
Study finds South Africans living with HIV more resilient despite chronic pain

Study finds South Africans living with HIV more resilient despite chronic pain

When one thinks about chronic conditions that are commonly painful, HIV doesn't typically spring to mind. However, more than 50% of HIV-positive individuals experience a painful condition like headache, chest pain or neuropathy, and that pain is frequently experienced as moderate to severe in intensity. [More]
New dermatological treatment could potentially help prevent or reverse diabetic neuropathy

New dermatological treatment could potentially help prevent or reverse diabetic neuropathy

For the 25 percent of type-2 diabetes patients who suffer from numbness and extreme nerve pain in their feet, a new dermatological treatment being tested by Northwestern Medicine scientists could potentially help prevent and maybe even reverse the neuropathy. [More]
Study finds tight glycemic control provides no impact on patient-important microvascular outcomes

Study finds tight glycemic control provides no impact on patient-important microvascular outcomes

The glucocentric focus on lowering blood sugar in Type 2 diabetes may have short-circuited development of new diabetes therapies, according to a new paper published by Mayo Clinic researchers in the journal Circulation: Cardiovascular Quality and Outcomes. [More]
Scientists report new neurological complication from Zika virus infection

Scientists report new neurological complication from Zika virus infection

Dr. John England, Professor and Chair of Neurology at LSU Health New Orleans School of Medicine, and colleagues in Honduras and Venezuela have reported a new neurological complication of infection with the Zika virus. [More]
MDI Biological Laboratory receives NIH grant for research on peripheral neuropathy

MDI Biological Laboratory receives NIH grant for research on peripheral neuropathy

The MDI Biological Laboratory has announced that it has received a grant of $456,500 over two years from the National Institutes of Health for the study of peripheral neuropathy. [More]
Scientists unravel effect of prion proteins on the nerves

Scientists unravel effect of prion proteins on the nerves

Ever since the prion gene was discovered in 1985, its role and biological impact on the neurons has remained a mystery. [More]
Advertisement
Advertisement